AMPH vs TFC · P/E 12, rev $732.0M vs rev $24.54B
Amphastar P (AMPH) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
TFC (TFC) common stock.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. TFC currently screens at market cap $0.
Not investment advice. Open the AMPH and TFC stock pages for the full models.
Not investment advice.